Remifemin Menopause Tablets | Desertcart Argentina
Remifemin Menopause Tablets
ID del producto: 59901848
Transacción segura
Comprados juntos con frecuencia
Descripción
Heading Helps you approach menopause with confidence - naturally. Purpose Dietary Supplement Manufacturer Enzym Therap Active Ingredients Per Tablet: Black Cohosh Extract (Root and Rhizome) Equivalent to 20 mg; Lactose (Milk); Cellulose; Potato Starch; Magnesium Stearate; Natural Peppermint Flavor Directions Recommendations: One tablet in the morning and one tablet in the evening, with water. You can expect to notice improvements within a few weeks, with full benefits after using Remifemin twice daily for 4-12 weeks. Uses The natural, safe alternative to hormone replacement therapy (HRT) for menopausal symptoms.* With RemiSure Black Cohosh: Unique - Exclusive, standardized extract, subject of over 90 scientific papers. Proven to be safe and effective.* Safe - Completely hormone-free without plant-based estrogens that can affect breast and uterine cell growth. Can be used safely by women with a history of breast cancer who cannot take estrogen. Effective - Recent clinical study shows 70% reduction in hot flashes, night sweats, mood swings, irritability, and related occasional sleeplessness.* Estrogen Free. Warnings Consult your healthcare practitioner prior to use if you have a history of liver disease or are taking prescription drugs. Do not use if pregnant, considering pregnancy, or nursing. For a few consumers, gastric discomfort may occur but should not be persistent. If gastric discomfort persists or if you observe other side effects, discontinue use and see your healthcare practitioner. *THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
Preguntas comunes
Trustpilot
Trustscore 4.5 | Más de 7,300 reseñas
Abdullah B.
¡Excelente precio para un producto auténtico! ¡Envío internacional rápido también!
Hace 3 semanas
Alí H.
Envío rápido y embalaje excelente. La herramienta Leatherman parece de primera calidad y resistente.
